Follow BPI on Twitter
Wanda Neal
Vice President, Programs and Registration Services
Tel: +1 (301) 656-5900 ext. 111
E-mail: neal@pda.org
Registration inquiries:
Patresa Day
Assistant Manager of Registration and Customer Service
Tel: +1 (301) 656-5900 ext. 115
E-mail: day@pda.org
Exhibition/sponsorship inquiries:
David Hall
Vice President, Sales
Tel: +1 (301) 760-7373
Cell: +1 (240) 688-4405
Fax: +1 (301) 986-0296
E-mail: hall@pda.org
The PDA/FDA Adventitious Viruses in Biologics: Detection and Mitigation Strategies Workshop is being organized currently as a result of recent viral contamination events. This workshop is intended to encourage modernization in industry with respect to viral detection and control measures. Gaps in our current ability to detect, control and clear adventitious viruses; the availability of emerging technologies in areas where gaps exist; and CGMP expectations for adventitious virus detection and control, as well as consequences for noncompliance will be discussed.
This workshop will be held on December 1-3 in Bethesda, Maryland and will discuss current and updated manufacturing practices and processes designed to prevent adventitious viruses in biologics. It will also highlight the U.S. FDA’s regulatory expectations for product quality and purity with respect to adventitious agents.
Facility Design Strategies for Single-Use Technologies
Please join us for a free webinar addressing strategies for facility design in biopharmaceutical manufacturing:
Wednesday, 29 February 2012
8:00 AM and 1:00 PM EST
Presented by:
Ingrid Long, MSc
Research Engineer
GE Healthcare Life Sciences
During the webinar, Ms. Long will discuss the impact of different strategies for facility design, with a focus on the following topics:
* Replacement of traditional equipment with the single-use equivalent
* Biopharmaceutical manufacturing in a single room
* Benefits of facility design with respect to cost, risk, and flexibility